Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Kirk

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Nature Reviews. Clinical Oncology|September 9, 2010
T cells as trained killersRebecca Kirk
Nature Reviews. Clinical Oncology|August 12, 2010
Screening: Four-kallikrein panel to reduce unnecessary prostate biopsyRebecca Kirk
Nature Reviews. Clinical Oncology|July 9, 2010
NASA-based siRNA nanoparticlesRebecca Kirk
Nature Reviews. Clinical Oncology|April 1, 2011
Targeted therapies: high levels of target reduce efficacy?Rebecca Kirk
Nature Reviews. Nephrology|November 20, 2013
Hypertension: Uromodulin identified as a potential therapeutic targetRebecca Kirk
Nature Reviews. Clinical Oncology|April 25, 2012
Genetics: Polyglutamine repeats or cancer?Rebecca Kirk
Nature Reviews. Clinical Oncology|April 18, 2013
Genetics: The COGS are turning in breast, ovarian and prostate cancerRebecca Kirk
Nature Reviews. Clinical Oncology|December 19, 2012
Imaging: Red light warning sign for clear-cell renal cell carcinoma--REDECT reveals imaging biomarkerRebecca Kirk
Nature Reviews. Clinical Oncology|June 19, 2013
From ASCO-gynaecological cancer: Advances in cervical cancer screening and treatmentRebecca Kirk
Nature Reviews. Clinical Oncology|March 27, 2013
Breast cancer: Circulating tumour DNA the better of the blood biomarkersRebecca Kirk
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Nature Reviews. Clinical Oncology|September 9, 2010
T cells as trained killersRebecca Kirk
Nature Reviews. Clinical Oncology|August 12, 2010
Screening: Four-kallikrein panel to reduce unnecessary prostate biopsyRebecca Kirk
Nature Reviews. Clinical Oncology|July 9, 2010
NASA-based siRNA nanoparticlesRebecca Kirk
Nature Reviews. Clinical Oncology|April 1, 2011
Targeted therapies: high levels of target reduce efficacy?Rebecca Kirk
Nature Reviews. Nephrology|November 20, 2013
Hypertension: Uromodulin identified as a potential therapeutic targetRebecca Kirk
Nature Reviews. Clinical Oncology|April 25, 2012
Genetics: Polyglutamine repeats or cancer?Rebecca Kirk
Nature Reviews. Clinical Oncology|April 18, 2013
Genetics: The COGS are turning in breast, ovarian and prostate cancerRebecca Kirk
Nature Reviews. Clinical Oncology|December 19, 2012
Imaging: Red light warning sign for clear-cell renal cell carcinoma--REDECT reveals imaging biomarkerRebecca Kirk
Nature Reviews. Clinical Oncology|June 19, 2013
From ASCO-gynaecological cancer: Advances in cervical cancer screening and treatmentRebecca Kirk
Nature Reviews. Clinical Oncology|March 27, 2013
Breast cancer: Circulating tumour DNA the better of the blood biomarkersRebecca Kirk
Pageof 11